Moreover, the expression of CD103 has been associated with patient survival in diverse cancer types: melanoma (36), non-small cell lung carcinoma (NSCLC) (37, 38), bladder cancer (39), endometrial cancer (EC) (40), breast cancer (41), cervical cancer (42) and high-grade serous ovarian cancer (HGSC) (43, 44, 45, 46) (Table 1). This evidence concerns the gene ITGAE and melanoma.